Loading…
CFPB Whistleblower Incentives and Protection Act
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 10,564 other HR bills in the 118th — cohort avg 68d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (3)
2024 · fourth_quarter · Medical/Disease Research/Clinical Labs
Support reintroduction of the VALID Act (previously HR 4128). Support the PASTEUR Act to incentivize the development of novel antimicrobial medicines. (S1355 and HR2490) Support PAHPA Reauthorization and stress the importance of investing in public health and pandemic preparedness.
Client expense: Not reported · Firm income: Not reported
Referred to the House Committee on Financial Services.
Introduced in House
Congress.gov source codes: 1000, Intro-H
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · fourth_quarter · Consumer Issues/Safety/Products
Issues related to debt collection Issues related to credit reporting H.R. 2489 CFPB Dual Mandate and Economic Analysis Act H.R. 1382 Taking Account of Bureaucrats' Spending (TABS) Act H.R. 6038 CFPB-IG Reform Act H.R. 1313 Transparency in CFPB Cost-Benefit Analysis Act H.R. 2490 CFPB Whistleblower Incentives and Protection Act H.R. 1410 Consumer Financial Protection Commission Act H.R. 1749 Making the CFPB Accountable to Small Businesses Act H.R. 6584 - Encouraging Innovation and Protecting Consumers Act H.R.1773 Consumer Protection for Medical Debt Collections Act S.1362Transparency in CFPB Cost-Benefit Analysis Act H.R. 6003 - Medical Debt Relief Act of 2023
Client expense: $170,000 · Firm income: Not reported
Government targets: Consumer Financial Protection Bureau (CFPB), HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA)
2024 · third_quarter · Consumer Issues/Safety/Products
Issues related to debt collection Issues related to credit reporting H.R. 2489 CFPB Dual Mandate and Economic Analysis Act H.R. 1382 Taking Account of Bureaucrats' Spending (TABS) Act H.R. 6038 CFPB-IG Reform Act H.R. 1313 Transparency in CFPB Cost-Benefit Analysis Act H.R. 2490 CFPB Whistleblower Incentives and Protection Act H.R. 1410 Consumer Financial Protection Commission Act H.R. 1749 Making the CFPB Accountable to Small Businesses Act Encouraging Innovation and Protecting Consumers Act H.R.1773 Consumer Protection for Medical Debt Collections Act S.1362Transparency in CFPB Cost-Benefit Analysis Act H.R. 6003 - Medical Debt Relief Act of 2023
Client expense: $240,000 · Firm income: Not reported
Government targets: Consumer Financial Protection Bureau (CFPB), HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA)
2024 · third_quarter · Medical/Disease Research/Clinical Labs
Support reintroduction of the VALID Act (previously HR 4128). Support the PASTEUR Act to incentivize the development of novel antimicrobial medicines. (S1355 and HR2490) Support PAHPA Reauthorization and stress the importance of investing in public health and pandemic preparedness.
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · second_quarter · Government Issues
Seaman's Protection Act Crime Victims Fund False Claims Act Air 21 whistleblower FAA S 1524 Expanding Whistleblower Protection for Contractors Act of 2023 Emmers House CFPB HR 2490 Covid Fraud HR7129
Client expense: Not reported · Firm income: Not reported
Government targets: Commodity Futures Trading Commission (CFTC), Federal Aviation Administration (FAA), Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, Occupational Safety & Health Administration (OSHA), SENATE
2024 · second_quarter · Medical/Disease Research/Clinical Labs
Support reintroduction of the VALID Act (previously HR 4128). Support the PASTEUR Act to incentivize the development of novel antimicrobial medicines. (S1355 and HR2490) Support PAHPA Reauthorization and stress the importance of investing in public health and pandemic preparedness.
Client expense: $5,250 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · second_quarter · Consumer Issues/Safety/Products
Issues related to debt collection Issues related to credit reporting H.R. 2489 CFPB Dual Mandate and Economic Analysis Act H.R. 1382 Taking Account of Bureaucrats' Spending (TABS) Act H.R. 6038 CFPB-IG Reform Act H.R. 1313 Transparency in CFPB Cost-Benefit Analysis Act H.R. 2490 CFPB Whistleblower Incentives and Protection Act H.R. 1410 Consumer Financial Protection Commission Act H.R. 1749 Making the CFPB Accountable to Small Businesses Act Encouraging Innovation and Protecting Consumers Act H.R.1773 Consumer Protection for Medical Debt Collections Act S.1362Transparency in CFPB Cost-Benefit Analysis Act H.R. 6003 - Medical Debt Relief Act of 2023
Client expense: $230,000 · Firm income: Not reported
Government targets: Consumer Financial Protection Bureau (CFPB), HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA)
2024 · first_quarter · Medical/Disease Research/Clinical Labs
Support reintroduction of the VALID Act (previously HR 4128). Support the PASTEUR Act to incentivize the development of novel antimicrobial medicines. (S1355 and HR2490) Support PAHPA Reauthorization and stress the importance of investing in public health and pandemic preparedness.
Client expense: $5,702 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2024 · first_quarter · Consumer Issues/Safety/Products
Issues related to debt collection Issues related to credit reporting H.R. 2489 CFPB Dual Mandate and Economic Analysis Act H.R. 1382 Taking Account of Bureaucrats' Spending (TABS) Act H.R. 6038 CFPB-IG Reform Act H.R. 1313 Transparency in CFPB Cost-Benefit Analysis Act H.R. 2490 CFPB Whistleblower Incentives and Protection Act H.R. 1410 Consumer Financial Protection Commission Act H.R. 1749 Making the CFPB Accountable to Small Businesses Act Encouraging Innovation and Protecting Consumers Act H.R.1773 Consumer Protection for Medical Debt Collections Act S.1362Transparency in CFPB Cost-Benefit Analysis Act H.R. 6003 - Medical Debt Relief Act of 2023
Client expense: $210,000 · Firm income: Not reported
Government targets: Consumer Financial Protection Bureau (CFPB), HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA)
2023 · fourth_quarter · Medical/Disease Research/Clinical Labs
Support reintroduction of the VALID Act (previously HR 4128). Support the PASTEUR Act to incentivize the development of novel antimicrobial medicines. (S1355 and HR2490) Support PAHPA Reauthorization and stress the importance of investing in public health and pandemic preparedness.
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · fourth_quarter · Consumer Issues/Safety/Products
Issues related to debt collection Issues related to credit reporting H.R. 2489 CFPB Dual Mandate and Economic Analysis Act H.R. 1382 Taking Account of Bureaucrats' Spending (TABS) Act H.R. 6038 CFPB-IG Reform Act H.R. 1313 Transparency in CFPB Cost-Benefit Analysis Act H.R. 2490 CFPB Whistleblower Incentives and Protection Act H.R. 1410 Consumer Financial Protection Commission Act H.R. 1749 Making the CFPB Accountable to Small Businesses Act Encouraging Innovation and Protecting Consumers Act H.R.1773 Consumer Protection for Medical Debt Collections Act S.1362Transparency in CFPB Cost-Benefit Analysis Act
Client expense: $170,000 · Firm income: Not reported
Government targets: Consumer Financial Protection Bureau (CFPB), HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA)
2023 · third_quarter · Consumer Issues/Safety/Products
Issues related to debt collection Issues related to credit reporting H.R. 2489 CFPB Dual Mandate and Economic Analysis Act H.R. 1382 Taking Account of Bureaucrats' Spending (TABS) Act H.R. 6038 CFPB-IG Reform Act H.R. 1313 Transparency in CFPB Cost-Benefit Analysis Act H.R. 2490 CFPB Whistleblower Incentives and Protection Act H.R. 1410 Consumer Financial Protection Commission Act H.R. 1749 Making the CFPB Accountable to Small Businesses Act Encouraging Innovation and Protecting Consumers Act H.R.1773 Consumer Protection for Medical Debt Collections Act S.1362Transparency in CFPB Cost-Benefit Analysis Act
Client expense: $210,000 · Firm income: Not reported
Government targets: Consumer Financial Protection Bureau (CFPB), HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA)
2023 · third_quarter · Medical/Disease Research/Clinical Labs
Support reintroduction of the VALID Act (previously HR 4128). Support the PASTEUR Act to incentivize the development of novel antimicrobial medicines. (S1355 and HR2490)
Client expense: $5,109 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2023 · second_quarter · Consumer Issues/Safety/Products
Issues related to debt collection Issues related to credit reporting H.R. 2489 CFPB Dual Mandate and Economic Analysis Act H.R. 1382 Taking Account of Bureaucrats' Spending (TABS) Act H.R. 6038 CFPB-IG Reform Act H.R. 1313 Transparency in CFPB Cost-Benefit Analysis Act H.R. 2490 CFPB Whistleblower Incentives and Protection Act H.R. 1410 Consumer Financial Protection Commission Act H.R. 1749 Making the CFPB Accountable to Small Businesses Act Encouraging Innovation and Protecting Consumers Act H.R.1773Consumer Protection for Medical Debt Collections Act
Client expense: $190,000 · Firm income: Not reported
Government targets: Consumer Financial Protection Bureau (CFPB), HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA)
2023 · first_quarter · Consumer Issues/Safety/Products
Issues related to debt collection Issues related to credit reporting H.R. 2489 CFPB Dual Mandate and Economic Analysis Act H.R. 1382 Taking Account of Bureaucrats' Spending (TABS) Act H.R. 6038 CFPB-IG Reform Act H.R. 1313 Transparency in CFPB Cost-Benefit Analysis Act H.R. 2490 CFPB Whistleblower Incentives and Protection Act H.R. 1410 Consumer Financial Protection Commission Act H.R. 1749 Making the CFPB Accountable to Small Businesses Act Encouraging Innovation and Protecting Consumers Act
Client expense: $200,000 · Firm income: Not reported
Government targets: Consumer Financial Protection Bureau (CFPB), HOUSE OF REPRESENTATIVES, SENATE, Small Business Administration (SBA)
| Republican |
| PA |
| William R. Timmons IV | Republican | SC |